Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Anixa Biosciences IncFinancial_Report.xls
10-K - FORM 10-K - Anixa Biosciences Incd277634d10k.htm
EX-32.2 - STATEMENT OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 1350 - Anixa Biosciences Incd277634dex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Incd277634dex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Incd277634dex312.htm
EX-23.1 - CONSENT OF KPMG LLP - Anixa Biosciences Incd277634dex231.htm

Exhibit 32.1

Statement of Chief Executive Officer

Pursuant to Section 1350 of Title 18 of the United States Code

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Denis A. Krusos, the Chairman of the Board and Chief Executive Officer of CopyTele, Inc., hereby certifies that:

 

  1. The Company’s Form 10-K Annual Report for the fiscal year ended October 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

      /s/ Denis A. Krusos
    Denis A. Krusos
    Chairman of the Board and
January 30, 2012     Chief Executive Officer